The funding will enable the company in conducting Phase II human clinical trials for its potential drug candidate for vitiligo – an autoimmune disease that causes the loss of skin colour. Vitiligo has no cure.
Latest articles
Artificial Intelligence
AI-based multilingual chatbot ‘myBuddy’ for mental wellbeing
Manah Wellness has launched myBuddy, an AI-based multilingual chatbot, to assist employees with mental...
Information Tech (IT)
Ratan Tata cared about making India better: Tech execs pay tributes
His remarkable leadership, marked by a unique blend of humility and confidence, guided TCS...
Information Tech (IT)
TCS continues to hire in Q2, adds 5,726 employees
In the previous quarter Q1, the Tata group subsidiary had reversed the declining headcount...
Information Tech (IT)
TCS Q2 Results: Profit rises 5% YoY to Rs 11,909 crore, misses estimates
TCS Q2 Results: Tata Consultancy Services (TCS), India's leading software exporter, reported a 5%...
More like this
Artificial Intelligence
AI-based multilingual chatbot ‘myBuddy’ for mental wellbeing
Manah Wellness has launched myBuddy, an AI-based multilingual chatbot, to assist employees with mental...
Information Tech (IT)
Ratan Tata cared about making India better: Tech execs pay tributes
His remarkable leadership, marked by a unique blend of humility and confidence, guided TCS...
Information Tech (IT)
TCS continues to hire in Q2, adds 5,726 employees
In the previous quarter Q1, the Tata group subsidiary had reversed the declining headcount...